Skip to main content
An official website of the United States government
Email

2019 Technology Showcase

2019 Technology Showcase graphic Design

June 12, 2019 | 12:00 PM – 5:00 PM

Frederick National Laboratory Frederick, MD

Add to Outlook Calendar

It was great seeing you on June 12. Thank you for a great event!

In the News:

Hear about what was said about this event:

Event Overview

The 2019 Technology Showcase highlighted technologies being developed at the NCI and Frederick National Laboratory (FNL) to encourage technology licensing and collaborations, startup company formation and the translation of NCI discoveries into solutions to benefit patients.

  • Free, half-day event.
  • Hear from NCI and FNLCR inventors about technologies primed for technology commercialization and/or collaboration; great opportunity for regional companies and biotech stakeholders.
  • Panel sessions focused on technology commercialization.
  • Poster session highlighting NIH technologies for available for collaborative development and/or licensing presented by the NCI Technology Transfer Ambassadors Program.
  • Networking, including an independently sponsored networking event nearby without involving any resources of the Department of Health and Human Services.
Frederick National Laboratory

Detailed Event Schedule

Event Agenda
Program Schedule Topics and Events
12:00 - 12:30 p.m.

Welcome & Keynote Presenters

Richard Bendis, President and CEO of BioHealth Innovation, Inc.
12:30 - 1:25 p.m.

Technology Session 1

The 2019 Technology Showcase highlighted technologies being developed at the NCI and Frederick National Laboratory (FNL) to encourage technology licensing and collaborations, startup company formation and the translation of NCI discoveries into solutions to benefit patients.

  • Chuong Hoang, M.D., NCI CCR, Thoracic Surgery Branch – "Nanoparticle-hydrogel Composite for Nucleic Acid Molecule Delivery" (E-080-2018)
  • Nan Li, Ph.D., NCI CCR, Laboratory of Molecular Biology – "High Affinity Monoclonal Antibodies Targeting Glypican-1" (E-028-2019)
  • Kumaran S. Ramamurthi, Ph.D., NCI CCR Laboratory of Molecular Biology – "Nanoparticle Platform Using Bacterial Spore Coat Proteins" (E-098-2015)
  • De Yang, M.D., Ph.D., NCI Center for Cancer Research (CCR), Cancer and Inflammation Program – "Therapeutic Antitumor Combination Containing TLR4 Agonist HMGN1" (E-069-2016)
  • Josip Blonder, M.D., FNLCR Antibody Characterization Laboratory – “Renal Carcinoma Biomarkers” (E-317-2008)

1:30 - 2:25 p.m.

Panel Sessions 1

Panels offered concurrently. Attendee selects one.

Panel 1: Making your company attractive to equity investors

Moderator: Martin Rosendale, CEO, Maryland Technology Council
Panelists:

  • Phillip Jung, Associate Maryland Venture Fund
  • Matthew Miessau, Analyst, Epidarex Capital

Panel 2: Partnering with the NCI and FNL to benefit your pipeline and your bottom-line

Moderator: Michael Salgaller, Ph.D., Supervisor, NCI Technology Transfer Center (TTC), Invention Development and Marketing Unit
Panelists:

  • Andrew Ishizuka, Ph.D., CSO, Avidea Technologies, Inc.
  • Vladimir Popov, Ph.D., Director, Partnership Development Office at Frederick National Laboratory for Cancer Research
  • Thomas Stackhouse, Ph.D., Director, NCI TTC
2:25 - 2:40 p.m.

Technology Transfer Ambassadors Program (TTAP) Lightning Poster Pitches

Posters prepared by TTAP Ambassadors will highlight the following technologies that are available for licensing and/or partnering.

  1. Presented by: 2017 Ambassador Alum, David Wei, Ph.D.
    Inventor: Bruce Shapiro, Ph.D., NCI Center for Cancer Research (CCR) RNA Biology Laboratory – “Nanoparticles for the Targeted Treatment of Infected Cells” (*E-039-2012)
  2. *Presented by: 2018 Ambassador Alum, Jyoti Roy, Ph.D.
    Inventor: Haksong Jin, PharmD, MS – “Topical Sodium Nitrate Ointment for Sickle Cell Disease” (E-149-2014)
  3. *Presented by: 2019 TTAP Ambassador, Sanket Awate, Ph.D.
    Inventor: Arya Biragyn, Ph.D., National Institute on Aging (NIA), Laboratory of Molecular Biology and Immunology – “Novel Regulatory B cells for Treatment of Cancer and Autoimmune Disease” (E-101-2010)
  4. Presented by: 2019 TTAP Ambassador, Sanket Awate, Ph.D.
    Inventor: Christopher Ramsden, M.D., NIA, Laboratory of Clinical Investigation / Lipid Peroxidation Unit – “Fatty Acid Derivatives and Their Use” (E-151-2017)
  5. Presented by: 2019 TTAP Ambassador, Mukta Nag, Ph.D.
    Inventor: George Pavlakis M.D., Ph.D., NCI CCR, Vaccine Branch – “Conserved Elements Vaccine for HIV” (E-132-2012)
  6. *Presented by: 2019 TTAP Ambassador, Suna Gulay, Ph.D.
    Inventor: Kenzie Preston, Ph.D., National Institute of Drug Abuse (NIDA), Clinical Pharmacology and Therapeutics Research Branch – "A Mobile Health Platform" (E-049-2015)
  7. Presented by: 2019 TTAP Ambassador, Suna Gulay, Ph.D.
    Inventor: James Kochenderfer, M.D., NCI CCR Experimental Transplantation and Immunology Branch – “Anti-SLAMF7 Chimeric Antigen Receptors” (E-158-2018)
  8. Presented by: 2019 TTAP Ambassador, Devanand Bondage, Ph.D.
    Inventor: Louis Staudt, M.D., Ph.D., NCI CCR Lympoid Malignancies Branch – “Using a Proximity Ligation Assay to Diagnose Lymphoma Subsets and Predict Patient Responses to Targeted Therapies” (E-171-2017)
  9. Presented by: 2019 TTAP Senior Ambassador and 2018 TTAP Alum, Sarwat Naz, Ph.D.
    Inventor: David Roberts, Ph.D., NCI CCR Laboratory of Pathology – “Method for Generating Pluripotent and Multipotent Cells” (E-086-2012)
  10. *Presented by: 2017 Ambassador Alum, Delphine Lissa, Ph.D.
    Inventor: Jeffrey Baron, M.D., NICHD, Section on Growth and Development – “Diagnostic Assays for the Detection of Thyroid Cancer” (E-016-2013)

*Select posters were developed through the TTAP partnership with the Johns Hopkins University (Carey Business School) “Discovery to Market” course.

If you are interested in learning more about these technologies and would like for someone to follow-up with you, please contact us at ncitechtransfer@mail.nih.gov.
2:40 - 3:10 p.m.

Technology Transfer Ambassadors Program (TTAP) Networking / Poster Session
3:10 - 4:00 p.m.

Technology Session 2

The 2019 Technology Showcase highlighted technologies being developed at the NCI and Frederick National Laboratory (FNL) to encourage technology licensing and collaborations, startup company formation and the translation of NCI discoveries into solutions to benefit patients.

  • Marina Dobrovolskaia, Ph.D., FNLCR Nanotechnology Characterization Lab – “Nucleic Acid Nanoparticles (NANP) and Methods of Using Same for Controlled Immunomodulation” (E-069-2018)
  • Dominic Esposito, Ph.D., FNLCR RAS Initiative – “New Insect Cell Technologies for Improved Protein Production” (E-287-2012, E-009-2015, E-146-2017)
  • Nadya Tarasova, Ph.D., NCI CCR Cancer and Inflammation Program – "Synthetic Lipopeptide Inhibitors of RAS Oncoproteins" (E-293-2010)
  • Stephan Stern, Ph.D., FNLCR Nanotechnology Characterization Lab – “Polymeric Delivery Platform for Therapeutics” (E-097-2017)
  • Josip Blonder, M.D., FNLCR Antibody Characterization Laboratory – “Renal Carcinoma Biomarkers” (E-317-2008)
4:05 - 4:55 p.m.

Panel Sessions 2

Panels offered concurrently. Attendee selects one.

Panel 1: Non-dilutive sources of funding for commercializing technology

Moderator: Darryl Sampey, Ph.D., President and CEO, BioFactura
Panelists:

  • Christie Canaria, Ph.D., Program Director, NIH/NCI/SBIR Development Center
  • Barry Datlof, M.B.A., Chief, Business Development and Commercialization, US Army Medical Research and Materiel Command
  • Javeed Froozan, VP, Research Business Development & Strategic Alliances, Leukemia & Lymphoma Society

Panel 2: Leveraging incubators and accelerators for technology licensing and commercialization

Moderator: Michael Binko, President and CEO, Startup Maryland
Panelists:

  • Kathie Callahan Brady, President and CEO, Frederick Innovative Technology Center, Inc. (FITCI)
  • Rosemarie Truman, Founder and CEO, the Center for Advancing Innovation
  • Jon A. Rowley, Ph.D., Founder and Chief Product Officer, RoosterBio, Inc.
Email